![Quinolones 1. Older (Earlier) quinolones include: Nalidixic acid, oxalinic acid and cinoxacin. 2. Fluorinated derivatives (Fluoroquinolones) include : - ppt download Quinolones 1. Older (Earlier) quinolones include: Nalidixic acid, oxalinic acid and cinoxacin. 2. Fluorinated derivatives (Fluoroquinolones) include : - ppt download](https://slideplayer.com/13020475/79/images/slide_1.jpg)
Quinolones 1. Older (Earlier) quinolones include: Nalidixic acid, oxalinic acid and cinoxacin. 2. Fluorinated derivatives (Fluoroquinolones) include : - ppt download
![Resurrection of Nalidixic Acid: Evaluation of Water-Based Nanoformulations as Potential Nanomedicine | Nanoscale Research Letters | Full Text Resurrection of Nalidixic Acid: Evaluation of Water-Based Nanoformulations as Potential Nanomedicine | Nanoscale Research Letters | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs11671-018-2718-8/MediaObjects/11671_2018_2718_Fig13_HTML.png)
Resurrection of Nalidixic Acid: Evaluation of Water-Based Nanoformulations as Potential Nanomedicine | Nanoscale Research Letters | Full Text
![Pharmaceuticals | Free Full-Text | A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies | HTML Pharmaceuticals | Free Full-Text | A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-01010/article_deploy/html/images/pharmaceuticals-15-01010-g001.png)
Pharmaceuticals | Free Full-Text | A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies | HTML
![Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli | Communications Biology Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-021-02074-5/MediaObjects/42003_2021_2074_Fig3_HTML.png)
Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli | Communications Biology
![Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli | Communications Biology Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-021-02074-5/MediaObjects/42003_2021_2074_Fig4_HTML.png)
Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli | Communications Biology
Use of a MAMA-PCR Method to detect gyrA Mutations in Nalidixic Acid Resistant Clinical Isolates of Escherichia coli
The effect of infinitesimal drug dilutions on the pharmacokinetics of nalidixic acid and atenolol. - Abstract - Europe PMC
![Pharmaceuticals | Free Full-Text | A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies | HTML Pharmaceuticals | Free Full-Text | A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-01010/article_deploy/html/images/pharmaceuticals-15-01010-g006.png)